Radius Health Inc. (RDUS): Radius Health Announces Oral Presentatio...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	77
Posts	3964
Boards Moderated	0
Alias Born	08/09/2004

Blutribe

Re: None

Wednesday, 06/18/2014 10:51:46 AM

Wednesday, June 18, 2014 10:51:46 AM

Radius Health Announces Oral Presentations at the International Society of Endocrinology and the Endocrine Society

CAMBRIDGE, Mass., June 18, 2014 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS), will present scientific data from studies conducted with abaloparatide (BA058) at the joint meeting of the International Society of Endocrinology and the Endocrine Society (ICE/ENDO 2014) in Chicago, Illinois, June 21-24, 2014.

Abstracts related to Radius Health include:

Title: A Transdermal Patch Delivering the PTHrP1-34 Analog, Abaloparatide (BA058), Dose-Dependently Increases Spine and Hip BMD Compared to Placebo
Abstract #: OR22-4
Presenter: Alan G. Harris, MD, PhD, FRCP
Presentation date/time: Sunday June 22, 12:15pm.
Session: OR22-Osteoporosis-Clinical Trials Clinical
Room/Details: W181 (McCormick Place West Building)

BUY them when OVERSOLD..SELL them when OVERBOUGHT...don't chase them at the top!

All posts are my opinion only. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!